Gabrielle van Caloen

Employment

• Université Catholique de Louvain PhD Student
  2014 - 2019

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Erythroferrone Modulates Osteoblast-Osteoclast Crosstalk During Bone Remodeling
  2026 DOI: 10.64898/2026.05.05.722997
  +Save
• Absence of phosphorylated CDK4, a biomarker of intrinsic resistance to CDK4/6 inhibitors in head and neck squamous cell carcinoma, can be predicted by their gene expression profile
  2025 DOI: 10.1101/2025.11.10.25339594
  +Save
• Preclinical Evaluation of the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor, Ribociclib, and Cetuximab in Squamous Cell Carcinoma of the Head and Neck
  Cancers 2021 DOI: 10.3390/cancers13061251
  +Save
• Preclinical Activity of Ribociclib in Squamous Cell Carcinoma of the Head and Neck.
  Molecular cancer therapeutics 2020 DOI: 10.1158/1535-7163.mct-19-0695
  +Save
• Potential role of cyclin-dependent kinase 4/6 inhibitors in the treatment of squamous cell carcinoma of the head and neck.
  Current opinion in oncology 2019 DOI: 10.1097/cco.0000000000000513
  +Save
• Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic p16-Negative Squamous Cell Carcinoma of the Head and Neck.
  Frontiers in oncology 2019 DOI: 10.3389/fonc.2019.00155
  +Save